Inventor · disambiguated record
Meizhong Xu
Also filed as: XU MEIZHONG
40 granted patents·17 pending applications·734 citations·filing 2004–2024
98Inventor score
Top patents by PatentIndex Score
57 records- 0199US11566026B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Jan 31, 2023·16 cites·19 claims
- 0299US7767675B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2007·Granted Aug 3, 2010·85 cites·85 claims
- 0398US10947230B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2019·Granted Mar 16, 2021·26 cites·44 claims
- 0498US10813930B2Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3INCYTE CORP·Filed 2019·Granted Oct 27, 2020·27 cites·42 claims
- 0598US10793565B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2019·Granted Oct 6, 2020·27 cites·16 claims
- 0698US10213427B2Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3INCYTE CORP·Filed 2016·Granted Feb 26, 2019·34 cites·39 claims
- 0798US9533984B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2014·Granted Jan 3, 2017·42 cites·6 claims
- 0898US9266892B2Fused pyrazoles as FGFR inhibitorsINCYTE CORP·Filed 2013·Granted Feb 23, 2016·40 cites·40 claims
- 0997US9533954B2Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3INCYTE CORP·Filed 2014·Granted Jan 3, 2017·42 cites·26 claims
- 1097US8754114B2Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3YAO WENQING·Filed 2011·Granted Jun 17, 2014·49 cites·26 claims
- 1197US8461330B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsZHUO JINCONG·Filed 2010·Granted Jun 11, 2013·40 cites·25 claims
- 1296US7776874B2Amido compounds and their use as pharmaceuticalsINCYTE CORP·Filed 2008·Granted Aug 17, 2010·27 cites·24 claims
- 1396US7304081B2Amido compounds and their use as pharmaceuticalsINCYTE CORP·Filed 2005·Granted Dec 4, 2007·42 cites·25 claims
- 1495US9944645B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE HOLDINGS CORP·Filed 2016·Granted Apr 17, 2018·15 cites·15 claims
- 1595US9695168B2Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2015·Granted Jul 4, 2017·27 cites·63 claims
- 1695US8058288B2Amido compounds and their use as pharmaceuticalsYAO WENQING·Filed 2010·Granted Nov 15, 2011·22 cites·35 claims
- 1794US11472791B2Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitorsINCYTE CORP·Filed 2020·Granted Oct 18, 2022·7 cites·31 claims
- 1894US9126927B2Amido compounds and their use as pharmaceuticalsYAO WENQING·Filed 2011·Granted Sep 8, 2015·20 cites·33 claims
- 1994US7683060B2Triazolotriazines as kinase inhibitorsINCYTE CORP·Filed 2007·Granted Mar 23, 2010·25 cites·152 claims
- 2093US10640503B2Imidazopyridines and imidazopyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2018·Granted May 5, 2020·7 cites·66 claims
- 2193US8071624B2N-substituted piperidines and their use as pharmaceuticalsYAO WENQING·Filed 2005·Granted Dec 6, 2011·26 cites·43 claims
- 2292US10738052B2Imidazotriaines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2018·Granted Aug 11, 2020·3 cites·18 claims
- 2392US9801877B2AZA spiro alkane derivatives as inhibitors of metalloproteasesINCYTE CORP·Filed 2016·Granted Oct 31, 2017·7 cites·18 claims
- 2492US7687665B22-methylprop anamides and their use as pharmaceuticalsINCYTE CORP·Filed 2005·Granted Mar 30, 2010·24 cites·28 claims
- 2589US9957229B2Amido compounds and their use as pharmaceuticalsINCYTE CORP·Filed 2017·Granted May 1, 2018·4 cites·6 claims
- 2689US7723349B2Aza spiro alkane derivatives as inhibitors of metalloproteasesINCYTE CORP·Filed 2004·Granted May 25, 2010·21 cites·15 claims
- 2789US2025223291A1Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 2886US8039471B2Aza spiro alkane derivatives as inhibitors of metalloproteasesINCYTE CORP·Filed 2008·Granted Oct 18, 2011·5 cites·17 claims
- 2985US8143251B2Triazolotriazines as kinase inhibitorsZHUO JINCONG·Filed 2011·Granted Mar 27, 2012·7 cites·17 claims
- 3084US7915408B2Triazolotriazines as kinase inhibitorsINCYTE CORP·Filed 2010·Granted Mar 29, 2011·6 cites·29 claims
- 3183US8637497B2AZA spiro alkane derivatives as inhibitors of metalloproteasesYAO WENQING·Filed 2011·Granted Jan 28, 2014·4 cites·10 claims
- 3282US12084449B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2022·Granted Sep 10, 2024·0 cites·1 claims
- 3382US9403775B2AZA spiro alkane derivatives as inhibitors of metalloproteasesINCYTE CORP·Filed 2013·Granted Aug 2, 2016·3 cites·22 claims
- 3480US2023146129A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 3579US12466828B2Bicyclic amines as CDK2 inhibitorsINCYTE CORP·Filed 2023·Granted Nov 11, 2025·0 cites·47 claims
- 3679US10047086B2Imidazopyridines and imidazopyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2017·Granted Aug 14, 2018·2 cites·65 claims
- 3777US8110581B2Lactam compounds and their use as pharmaceuticalsYAO WENQING·Filed 2008·Granted Feb 7, 2012·2 cites·22 claims
- 3874US11261191B2Imidazotriaines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2020·Granted Mar 1, 2022·0 cites·21 claims
- 3970US2023226062A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 4068US2019127376A1Substituted tricyclic compounds as fgfr inhibitorsINCYTE CORP·Filed 2018·Application pending·0 cites
- 4167US2024415840A1Bicyclic amines as cdk2 inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 4266US10226459B2Aza spiro alkane derivatives as inhibitors of metalloproteasesINCYTE CORP·Filed 2017·Granted Mar 12, 2019·0 cites·10 claims
- 4365US2024083898A1Tricyclic triazolo compounds as dgk inhibitorsINCYTE CORP·Filed 2023·Application pending·0 cites
- 4464US2018179201A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2017·Application pending·0 cites
- 4564US2007179142A1Amido compounds and their use as pharmaceuticalsYAO WENQING·Filed 2007·Application pending·0 cites
- 4663US2013324515A1Imidazotriazines and imidazopyrimidines as kinase inhibitorsZHUO JINCONG·Filed 2013·Application pending·0 cites
- 4762US9670154B2Amido compounds and their use as pharmaceuticalsINCYTE CORP·Filed 2015·Granted Jun 6, 2017·0 cites·3 claims
- 4862US2023399342A1Tricyclic triazolo compounds as dgk inhibitorsINCYTE CORP·Filed 2023·Application pending·0 cites
- 4957US2018177784A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2017·Application pending·0 cites
- 5049US8563570B2Lactam compounds and their use as pharmaceuticalsYAO WENQING·Filed 2012·Granted Oct 22, 2013·0 cites·31 claims
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Meizhong Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →